Clinical Trial: A Study to Evaluate the Safety and Tolerability of TOS-358 in Adults With Select Solid Tumors
Study Status: Completed
Recruit Status: RECRUITING
Condition: Colorectal Cancer
Study Type: INTERVENTIONAL
Official Title: A Study to Evaluate the Safety and Tolerability of the Covalent Phosphoinositide-3-Kinase (PI3K)-Alpha Inhibitor, TOS-358, in Adult Subjects With Select Solid Tumors
Brief Summary:
The goal of this clinical trial is to evaluate the safety of TOS-358 in adults with select solid tumors who meet study enrollment criteria.The main questions it aims to answer are:what is the maximum tolerated dose and recommended dose for phase 2?how safe and tolerable is TOS-358 at different dose levels when taken orally once or twice per day?
Read more